STOCK TITAN

AN2 Therapeutics CEO Eric Easom reports 6.2% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

AN2 Therapeutics, Inc. (ANTX) common stock was beneficially owned by Chief Executive Officer Eric Easom in the amount of 2,409,486 shares, or 6.2% of the class, as of September 30, 2026. The total includes 97,943 shares held directly, 1,259,882 shares held by family trusts over which he serves as trustee, and 1,051,661 shares underlying options that were vested or will vest within 60 days of September 30, 2026. AN2 Therapeutics had 37,736,237 shares outstanding as of August 6, 2026.

Beneficial ownership 2,409,486 shares Eric Easom’s reported ownership as of September 30, 2026
Percent of class 6.2% Based on AN2 Therapeutics common stock
Shares held directly 97,943 shares Included in Easom’s reported beneficial ownership
Family-trust shares 1,259,882 shares Held by trusts over which Easom serves as trustee
Shares underlying stock options 1,051,661 shares Options vested or to vest within 60 days of September 30, 2026
Shares outstanding 37,736,237 shares AN2 Therapeutics shares outstanding as of August 6, 2026
beneficial ownership regulatory
"beneficial ownership of 2,409,486 shares of Common Stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole voting power regulatory
"Sole voting power 2,409,486"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole dispositive power 2,409,486"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
shares underlying stock options financial
"1,051,661 shares underlying stock options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ANTX shares did Eric Easom beneficially own?

Eric Easom reported beneficial ownership of 2,409,486 shares, equal to 6.2% of AN2 Therapeutics’ common stock, as of September 30, 2026. The amount includes shares held directly, shares held by family trusts over which he serves as trustee, and shares underlying options vested or to vest within 60 days of that date.

What holdings made up Eric Easom’s ANTX beneficial ownership?

The reported amount comprised 97,943 shares held directly, 1,259,882 shares held by family trusts over which Easom serves as trustee, and 1,051,661 shares underlying options that were vested or will vest within 60 days of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





037326105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Eric Easom
Signature:/s/ Eric Easom
Name/Title:Eric Easom, Chief Executive Officer
Date:11/13/2026

Keep reading